| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England Journal of Medicine 383 (6), 517-525, 2020 | 1564 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 640 | 2020 |
| Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open forum infectious diseases 7 (4), ofaa130, 2020 | 237 | 2020 |
| Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 CT Bramante, JD Huling, CJ Tignanelli, JB Buse, DM Liebovitz, ... New England Journal of Medicine 387 (7), 599-610, 2022 | 196 | 2022 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 99 | 2022 |
| Symptoms of COVID-19 outpatients in the United States MF Pullen, CP Skipper, KH Hullsiek, AS Bangdiwala, KA Pastick, ... Open forum infectious diseases 7 (7), ofaa271, 2020 | 72 | 2020 |
| Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19 SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ... Open forum infectious diseases 7 (11), ofaa500, 2020 | 58 | 2020 |
| The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era PB Mazi, JM Sahrmann, MA Olsen, A Coler-Reilly, AM Rauseo, M Pullen, ... Clinical Infectious Diseases, 2022 | 42 | 2022 |
| Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial SA Lother, M Abassi, A Agostinis, AS Bangdiwala, MP Cheng, G Drobot, ... Canadian Journal of Anesthesia/Journal canadien d'anesthésie 67 (9), 1201-1211, 2020 | 28 | 2020 |
| Genetic dissection of the Gpnmb network in the eye H Lu, X Wang, M Pullen, H Guan, H Chen, S Sahu, B Zhang, H Chen, ... Investigative ophthalmology & visual science 52 (7), 4132-4142, 2011 | 27 | 2011 |
| Protective immunogenicity of group A streptococcal M-related proteins JB Dale, SE Niedermeyer, T Agbaosi, ND Hysmith, TA Penfound, ... Clinical and Vaccine Immunology 22 (3), 344-350, 2015 | 25 | 2015 |
| Cerebrospinal fluid early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials MF Pullen, KH Hullsiek, J Rhein, AK Musubire, L Tugume, E Nuwagira, ... Clinical Infectious Diseases 71 (7), e45-e49, 2020 | 20 | 2020 |
| Lessons learned from conducting internet-based randomized clinical trials during a global pandemic MF Pullen, KA Pastick, DA Williams, AA Nascene, AS Bangdiwala, ... Open Forum Infectious Diseases 8 (2), ofaa602, 2021 | 11 | 2021 |
| Blastomycosis—Some Progress but Still Much to Learn MF Pullen, JD Alpern, NC Bahr Journal of Fungi 8 (8), 824, 2022 | 10 | 2022 |
| Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra polymerase chain reaction cycle threshold value predicts 2-week mortality in human immunodeficiency virus–associated … EM Martyn, AS Bangdiwala, E Kagimu, MK Rutakingirwa, J Kasibante, ... Clinical Infectious Diseases 73 (9), e3505-e3510, 2021 | 6 | 2021 |
| Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial. DR Boulware, TA Murray, JL Proper, CJ Tignanelli, JB Buse, DM Liebovitz, ... Clin. infect. dis, 2022 | 5 | 2022 |
| Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID … DR Boulware, TA Murray, JL Proper, CJ Tignanelli, JB Buse, DM Liebovitz, ... Clinical Infectious Diseases, 2022 | 3 | 2022 |
| Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra PCR Cycle Threshold value predicts two-week mortality in HIV-associated tuberculous meningitis EM Martyn, AS Bangdiwala, E Kagimu, MK Rutakingirwa, J Kasibante, ... Clin Infect Dis 73, e3505-e3510, 2020 | 3 | 2020 |
| Change in Plasma Cryptococcal Antigen Titer Is Not Associated with Survival Among Human Immunodeficiency Virus–infected Persons Receiving Preemptive Therapy for Asymptomatic … MF Pullen, F Kakooza, E Nalintya, AN Kiragga, BM Morawski, ... Clinical Infectious Diseases 70 (2), 353-355, 2020 | 3 | 2020 |
| Tuberculosis at the animal–human interface in the Ugandan cattle corridor using a third-generation sequencing platform: a cross-sectional analysis study MF Pullen, DR Boulware, S Sreevatsan, J Bazira BMJ open 9 (4), e024221, 2019 | 3 | 2019 |
